Lobectomy Versus Stereotactic Body Radiotherapy in Healthy Octogenarians With Stage I Lung Cancer

医学 肺癌 阶段(地层学) 危险系数 倾向得分匹配 比例危险模型 置信区间 全肺切除术 多元分析 生存分析 放射治疗 放射外科 内科学 肿瘤科 外科 古生物学 生物
作者
Syed S. Razi,Karishma Kodia,Ahmed Alnajar,Mark I. Block,Francisco Tarrazzi,Dao M. Nguyen,Nestor Villamizar
出处
期刊:The Annals of Thoracic Surgery [Elsevier BV]
卷期号:111 (5): 1659-1665 被引量:22
标识
DOI:10.1016/j.athoracsur.2020.06.097
摘要

BackgroundStereotactic body radiation therapy (SBRT) is increasingly being offered for early stage non-small cell lung cancer (NSCLC). We sought to evaluate long-term survival outcomes after lobectomy and SBRT in patients aged 80 years or more with stage I NSCLC.MethodsThe National Cancer Database was queried for patients with clinical stage IA and IB (size 40 mm or smaller) NSCLC who underwent SBRT or lobectomy. Only patients with no comorbidities were selected. Number of lymph nodes (LN) examined was used to stratify lobectomy patients into 0 LN, 1 to 6 LN, and 7 or more LN. Propensity score analysis was used to adjust treatment groups. Kaplan-Meier and multivariate Cox regression analysis were used for survival analysis.ResultsA total of 8964 patients with stage I NSCLC treated with lobectomy were compared with 286 patients who received SBRT. Using propensity matched pairs, lobectomy (7 LN or more) had significantly improved survival as compared with SBRT (median 74 vs 53.2 months, P < .05); however, no survival differences were observed when 0 LN were sampled (median 53.8 vs 52.3 months, P = .88). In multivariate analysis, lobectomy was associated with significantly improved survival (hazard ratio 0.726; 95% confidence interval; 0.580 to 0.910; P = .005). In addition, age, sex, high grade, and tumor size were independent predictors of survival.ConclusionsAmong healthy octogenarians with clinical stage I NSCLC who are good surgical candidates, lobectomy offers better survival than SBRT. Adequate LN dissection allows true nodal staging and opportunity for adjuvant treatment when unsuspected nodal metastases are found. Stereotactic body radiation therapy (SBRT) is increasingly being offered for early stage non-small cell lung cancer (NSCLC). We sought to evaluate long-term survival outcomes after lobectomy and SBRT in patients aged 80 years or more with stage I NSCLC. The National Cancer Database was queried for patients with clinical stage IA and IB (size 40 mm or smaller) NSCLC who underwent SBRT or lobectomy. Only patients with no comorbidities were selected. Number of lymph nodes (LN) examined was used to stratify lobectomy patients into 0 LN, 1 to 6 LN, and 7 or more LN. Propensity score analysis was used to adjust treatment groups. Kaplan-Meier and multivariate Cox regression analysis were used for survival analysis. A total of 8964 patients with stage I NSCLC treated with lobectomy were compared with 286 patients who received SBRT. Using propensity matched pairs, lobectomy (7 LN or more) had significantly improved survival as compared with SBRT (median 74 vs 53.2 months, P < .05); however, no survival differences were observed when 0 LN were sampled (median 53.8 vs 52.3 months, P = .88). In multivariate analysis, lobectomy was associated with significantly improved survival (hazard ratio 0.726; 95% confidence interval; 0.580 to 0.910; P = .005). In addition, age, sex, high grade, and tumor size were independent predictors of survival. Among healthy octogenarians with clinical stage I NSCLC who are good surgical candidates, lobectomy offers better survival than SBRT. Adequate LN dissection allows true nodal staging and opportunity for adjuvant treatment when unsuspected nodal metastases are found.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
秋风的应助被快乐乐巧采纳,获得10
刚刚
刚刚
1秒前
linlianhao发布了新的文献求助10
1秒前
水煮电吹风的应助被www333ccc采纳,获得10
4秒前
4秒前
帅气鲨鱼发布了新的文献求助10
4秒前
snow完成签到 ,获得积分20
4秒前
5秒前
luyiyi发布了新的文献求助10
5秒前
5秒前
11发布了新的文献求助50
6秒前
星辰大海的应助被伶俐鹤轩采纳,获得20
6秒前
igiss发布了新的文献求助10
6秒前
完美世界的应助被别梦寒采纳,获得10
7秒前
芋圆发布了新的文献求助30
7秒前
隐形曼青的应助被潇洒盼柳采纳,获得30
8秒前
海芝士莓果酱完成签到,获得积分10
8秒前
8秒前
小花花发布了新的文献求助10
8秒前
9秒前
10秒前
10秒前
10秒前
10秒前
10秒前
11秒前
11秒前
12秒前
you完成签到,获得积分10
13秒前
简单面包完成签到,获得积分10
13秒前
14秒前
跳跃发布了新的文献求助10
14秒前
小马甲的应助被GBY采纳,获得10
14秒前
风清扬发布了新的文献求助10
14秒前
初景发布了新的文献求助10
15秒前
bkagyin的应助被爱吃香菜采纳,获得10
15秒前
小羊6680发布了新的文献求助10
15秒前
16秒前
zzk完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177849
求助须知:如何正确求助?哪些是违规求助? 9568641
关于积分的说明 21800145
捐赠科研通 7772473
什么是DOI,文献DOI怎么找? 3432537
关于科研通互助平台的介绍 2556720
邀请新用户注册赠送积分活动 2478067